PHS
GILD icon

Pekin Hardy Strauss’s Gilead Sciences GILD Stock Holding History

Pekin Hardy Strauss’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$545K Sell
3,908
-65
-2% -$9.1K 0.06% 291
2025
Q4 		$488K Sell
3,973
-17
-0.4% -$2.07K 0.05% 281
2025
Q3 		$443K Sell
3,990
-720
-15% -$81.8K 0.04% 270
2025
Q2 		$522K Sell
4,710
-301
-6% -$32K 0.06% 236
2025
Q1 		$561K Buy
5,011
+1
+0% +$103 0.07% 233
2024
Q4 		$463K Sell
5,010
-1,270
-20% -$114K 0.06% 254
2024
Q3 		$527K Buy
6,280
+733
+13% +$55.9K 0.07% 233
2024
Q2 		$381K Sell
5,547
-105
-2% -$7.01K 0.05% 247
2024
Q1 		$414K Hold
5,652
– – 0.06% 237
2023
Q4 		$458K Hold
5,652
– – 0.06% 206
2023
Q3 		$424K Hold
5,652
– – 0.07% 204
2023
Q2 		$436K Sell
5,652
-80
-1% -$6.38K 0.05% 200
2023
Q1 		$476K Hold
5,732
– – 0.06% 199
2022
Q4 		$492K Sell
5,732
-906
-14% -$71.7K 0.07% 196
2022
Q3 		$409K Sell
6,638
-112
-2% -$7.06K 0.07% 204
2022
Q2 		$417K Hold
6,750
– – 0.06% 218
2022
Q1 		$401K Sell
6,750
-1,000
-13% -$63.9K 0.05% 250
2021
Q4 		$563K Sell
7,750
-1,100
-12% -$75.8K 0.08% 212
2021
Q3 		$618K Sell
8,850
-55
-0.6% -$3.86K 0.09% 204
2021
Q2 		$613K Sell
8,905
-2,375
-21% -$159K 0.09% 200
2021
Q1 		$729K Sell
11,280
-639
-5% -$41.2K 0.12% 168
2020
Q4 		$694K Buy
11,919
+1,010
+9% +$60.9K 0.12% 157
2020
Q3 		$689K Sell
10,909
-1,056
-9% -$73.2K 0.14% 139
2020
Q2 		$921K Sell
11,965
-7,815
-40% -$599K 0.2% 102
2020
Q1 		$1.48M Buy
19,780
+10,090
+104% +$697K 0.33% 69
2019
Q4 		$630K Buy
9,690
+300
+3% +$19.5K 0.1% 133
2019
Q3 		$595K Hold
9,390
– – 0.12% 126
2019
Q2 		$634K Sell
9,390
-300
-3% -$19.7K 0.13% 120
2019
Q1 		$630K Sell
9,690
-2,770
-22% -$184K 0.05% 116
2018
Q4 		$779K Sell
12,460
-1,087
-8% -$76K 0.14% 99
2018
Q3 		$1.05M Sell
13,547
-65
-0.5% -$4.91K 0.18% 94
2018
Q2 		$964K Sell
13,612
-476
-3% -$33.6K 0.18% 91
2018
Q1 		$1.06M Buy
14,088
+350
+3% +$27.8K 0.19% 90
2017
Q4 		$984K Sell
13,738
-1,171
-8% -$88.9K 0.18% 92
2017
Q3 		$1.21M Sell
14,909
-699
-4% -$53.5K 0.23% 82
2017
Q2 		$1.1M Buy
15,608
+111
+0.7% +$7.39K 0.17% 82
2017
Q1 		$1.05M Sell
15,497
-299
-2% -$21K 0.21% 80
2016
Q4 		$1.13M Buy
15,796
+4,227
+37% +$314K 0.1% 76
2016
Q3 		$915K Buy
11,569
+3,001
+35% +$244K 0.16% 83
2016
Q2 		$715K Sell
8,568
-2,564
-23% -$228K 0.16% 88
2016
Q1 		$1.02M Sell
11,132
-1,549
-12% -$140K 0.24% 77
2015
Q4 		$1.28M Buy
12,681
+400
+3% +$41.6K 0.29% 66
2015
Q3 		$1.21M Buy
12,281
+781
+7% +$86.7K 0.28% 66
2015
Q2 		$1.35M Buy
11,500
+745
+7% +$81.4K 0.26% 65
2015
Q1 		$1.05M Sell
10,755
-2,410
-18% -$245K 0.2% 66
2014
Q4 		$1.24M Buy
13,165
+5,320
+68% +$550K 0.18% 106
2014
Q3 		$835K Sell
7,845
-6,015
-43% -$589K 0.14% 63
2014
Q2 		$1.15M Buy
13,860
+7,610
+122% +$592K 0.18% 57
2014
Q1 		$443K Buy
6,250
+3,500
+127% +$274K 0.07% 82
2013
Q4 		$207K Sell
2,750
-5,350
-66% -$373K 0.03% 120
2013
Q3 		$509K Buy
8,100
+2,595
+47% +$155K 0.08% 74
2013
Q2 		$282K Buy
+5,505
New +$287K 0.05% 105

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Pekin Hardy Strauss's GILD Position: Q1 2026 in Review

Pekin Hardy Strauss reduced its Gilead Sciences (GILD) stake by 1.6% in Q1 2026, selling an estimated $9.1K and leaving 3,908 shares worth $545K. The position accounts for 0.06% of the portfolio, ranked #291.

Pekin Hardy Strauss first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.48M in Q1 2020. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Pekin Hardy Strauss held 3,908 shares of Gilead Sciences worth $545K as of Q1 2026.
  • Pekin Hardy Strauss sold 65 Gilead Sciences shares in Q1 2026, an estimated $9.1K.
  • Gilead Sciences made up 0.06% of Pekin Hardy Strauss's portfolio in Q1 2026, its #291 holding.
  • Pekin Hardy Strauss first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Pekin Hardy Strauss's Gilead Sciences position peaked at $1.48M in Q1 2020.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Pekin Hardy Strauss's 13F filing for Q1 2026, filed 7 May 2026.